Skip to main content
[Translate to English:]

Novo Nordisk Pharma GmbH

Dr. Robert Haustein, Senior Manager Govermental Affairs, Head of Capital Office, Novo Nordisk Pharma GmbH

 

1. Describe your company in a Tweet! 

Novo Nordisk is a global leader in healthcare, founded in 1923 and headquartered in Denmark. We drive change with the goal of defeating diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. To do this, we are working on breakthrough scientific innovations to the point of curing diseases. We promote access to our products for patients worldwide and are actively engaged in prevention. Novo Nordisk employs around 45,000 people in 80 countries and markets its products in around 170 countries. Around 480 employees work at the German headquarters in Mainz.

 

2. Why do you get involved as a Berlin Partner? 

As an internationally active company with Danish roots, we are convinced of Berlin and its importance for the healthcare industry in Germany and Europe.

 

Exclusive information for Berlin-Partners

Photocredit: © Novo Nordisk

TeilenShare

Weitere
Informationen
Further
Information

Berlin Partner reports strong midyear results

20.08.2025
Investors and companies continue to see high potential in the capital despite ongoing challenges

Read more

Innovation driver Berlin

04.08.2025
Berlin ranks 12th on the European Commission's Regional Innovation Scoreboard.

Read more

Berlin is knorke: Floating weld seams

28.07.2025
The innovative welding technology from WeldNova GmbH significantly accelerates the production of steel structures.

Read more

Fully automated

16.07.2025
Senate study highlights potential of AI-driven robotics for Berlin’s industrial sector

Read more

Berlin goes India

10.07.2025
Strengthening economic ties with India: Berlin delegation visits Bengaluru and New Delhi

Read more

Berlin Hoffest Courtyard Festival 2025

02.07.2025
Networking at its best

Read more